Advertisement

Topics

Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer

12:16 EDT 15 Apr 2019 | ecancermedicalscience

Dr Constantia Pantelidou speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about a study which looked at the immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer (TNBC). She...

Original Article: Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer

NEXT ARTICLE

More From BioPortfolio on "Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...